These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35210848)

  • 1. Study Design Characteristics and Endpoints for Enriched Enrollment Randomized Withdrawal Trials for Chronic Pain Patients: A Systematic Review.
    Kopsky DJ; Szadek KM; Schober P; Vrancken AFJE; Steegers MAH
    J Pain Res; 2022; 15():479-496. PubMed ID: 35210848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain: a new framework for design and reporting.
    Moore RA; Wiffen PJ; Eccleston C; Derry S; Baron R; Bell RF; Furlan AD; Gilron I; Haroutounian S; Katz NP; Lipman AG; Morley S; Peloso PM; Quessy SN; Seers K; Strassels SA; Straube S
    Pain; 2015 Aug; 156(8):1382-1395. PubMed ID: 25985142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison between enriched and nonenriched enrollment randomized withdrawal trials of opioids for chronic noncancer pain.
    Furlan A; Chaparro LE; Irvin E; Mailis-Gagnon A
    Pain Res Manag; 2011; 16(5):337-51. PubMed ID: 22059206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of responder definition on the enriched enrollment randomized withdrawal trial design for establishing proof of concept in neuropathic pain.
    Hewitt DJ; Ho TW; Galer B; Backonja M; Markovitz P; Gammaitoni A; Michelson D; Bolognese J; Alon A; Rosenberg E; Herman G; Wang H
    Pain; 2011 Mar; 152(3):514-521. PubMed ID: 21185118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis.
    Langford RM; Mares J; Novotna A; Vachova M; Novakova I; Notcutt W; Ratcliffe S
    J Neurol; 2013 Apr; 260(4):984-97. PubMed ID: 23180178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a phase III, double-blind, randomized withdrawal, placebo-controlled study.
    Arnold LM; Arsenault P; Huffman C; Patrick JL; Messig M; Chew ML; Sanin L; Scavone JM; Pauer L; Clair AG
    Curr Med Res Opin; 2014 Oct; 30(10):2069-83. PubMed ID: 24867298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies.
    Fallon MT; Albert Lux E; McQuade R; Rossetti S; Sanchez R; Sun W; Wright S; Lichtman AH; Kornyeyeva E
    Br J Pain; 2017 Aug; 11(3):119-133. PubMed ID: 28785408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Once-Daily Controlled-Release Pregabalin for the Treatment of Patients With Postherpetic Neuralgia: A Double-Blind, Enriched Enrollment Randomized Withdrawal, Placebo-Controlled Trial.
    Huffman CL; Goldenberg JN; Weintraub J; Sanin L; Driscoll J; Yang R; Chew ML; Scavone JM
    Clin J Pain; 2017 Jul; 33(7):569-578. PubMed ID: 27753650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral tapentadol for cancer pain.
    Wiffen PJ; Derry S; Naessens K; Bell RF
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD011460. PubMed ID: 26403220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial.
    Schwartz S; Etropolski M; Shapiro DY; Okamoto A; Lange R; Haeussler J; Rauschkolb C
    Curr Med Res Opin; 2011 Jan; 27(1):151-62. PubMed ID: 21162697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological interventions for pain relief during orthodontic treatment.
    Monk AB; Harrison JE; Worthington HV; Teague A
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD003976. PubMed ID: 29182798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsiveness of efficacy endpoints in clinical trials with over the counter analgesics for headache.
    Aicher B; Peil H; Peil B; Diener HC
    Cephalalgia; 2012 Oct; 32(13):953-62. PubMed ID: 22763497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of outcomes and endpoints in acute migraine clinical trials.
    Houts CR; McGinley JS; Nishida TK; Buse DC; Wirth RJ; Dodick DW; Goadsby PJ; Lipton RB
    Headache; 2021 Feb; 61(2):263-275. PubMed ID: 33611818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tramadol/Dexketoprofen Analgesic Efficacy Compared with Tramadol/Paracetamol in Moderate to Severe Postoperative Acute Pain: Subgroup Analysis of a Randomized, Double-Blind, Parallel Group Trial-DAVID Study.
    Hanna M; Montero A; Perrot S; Varrassi G
    Pain Ther; 2021 Jun; 10(1):485-503. PubMed ID: 33575951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tramadol/dexketoprofen (TRAM/DKP) compared with tramadol/paracetamol in moderate to severe acute pain: results of a randomised, double-blind, placebo and active-controlled, parallel group trial in the impacted third molar extraction pain model (DAVID study).
    Gay-Escoda C; Hanna M; Montero A; Dietrich T; Milleri S; Giergiel E; Zoltán TB; Varrassi G
    BMJ Open; 2019 Feb; 9(2):e023715. PubMed ID: 30782886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebulized versus intravenous morphine titration for the initial treatment of severe acute pain in the emergency department: study protocol for a multicenter, prospective randomized and controlled trial, CLIN-AEROMORPH.
    Lvovschi VE; Joly J; Lemaire N; Maignan M; Canavaggio P; Leroi AM; Tavolacci MP; Joly LM
    Trials; 2019 Apr; 20(1):209. PubMed ID: 30975187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of Phase 3 Studies Evaluating Vixotrigine for Treatment of Trigeminal Neuralgia.
    Kotecha M; Cheshire WP; Finnigan H; Giblin K; Naik H; Palmer J; Tate S; Zakrzewska JM
    J Pain Res; 2020; 13():1601-1609. PubMed ID: 32669869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enriched enrollment randomized withdrawal trial designs of analgesics: focus on methodology.
    Katz N
    Clin J Pain; 2009; 25(9):797-807. PubMed ID: 19851161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.